Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaname Akamata

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Dermatology|October 16, 2018
Japanese familial anetoderma: A report of two cases and review of the published workMaiko Fukayama, Tomomitsu Miyagaki, Kaname Akamata, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient miceTakashi Taniguchi, Yoshihide Asano, Kaname Akamata, et al.
Arthritis Research & Therapy|April 9, 2014
Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1Kaname Akamata, Yoshihide Asano, Naohiko Aozasa, et al.
International Wound Journal|November 5, 2019
Rapid detection of biofilm by wound blotting following sharp debridement of chronic pressure ulcers predicts wound healing: A preliminary studyGojiro Nakagami, Gregory Schultz, Aya Kitamura, et al.
Modern Rheumatology|November 15, 2011
Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosisNaohiko Aozasa, Yoshihide Asano, Kaname Akamata, et al.
Archives of Dermatological Research|April 25, 2012
Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphomaTomomitsu Miyagaki, Makoto Sugaya, Hiraku Suga, et al.
The Journal of Investigative Dermatology|March 12, 2016
Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune CellsTetsuo Toyama, Yoshihide Asano, Kaname Akamata, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding abilityKaname Akamata, Yoshihide Asano, Takashi Yamashita, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosisTakehiro Takahashi, Yoshihide Asano, Yohei Ichimura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic SclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Dermatology|October 16, 2018
Japanese familial anetoderma: A report of two cases and review of the published workMaiko Fukayama, Tomomitsu Miyagaki, Kaname Akamata, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient miceTakashi Taniguchi, Yoshihide Asano, Kaname Akamata, et al.
Arthritis Research & Therapy|April 9, 2014
Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1Kaname Akamata, Yoshihide Asano, Naohiko Aozasa, et al.
International Wound Journal|November 5, 2019
Rapid detection of biofilm by wound blotting following sharp debridement of chronic pressure ulcers predicts wound healing: A preliminary studyGojiro Nakagami, Gregory Schultz, Aya Kitamura, et al.
Modern Rheumatology|November 15, 2011
Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosisNaohiko Aozasa, Yoshihide Asano, Kaname Akamata, et al.
Archives of Dermatological Research|April 25, 2012
Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphomaTomomitsu Miyagaki, Makoto Sugaya, Hiraku Suga, et al.
The Journal of Investigative Dermatology|March 12, 2016
Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune CellsTetsuo Toyama, Yoshihide Asano, Kaname Akamata, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2015
Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1-knockout mice by increasing Fli-1 DNA binding abilityKaname Akamata, Yoshihide Asano, Takashi Yamashita, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 11, 2014
Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosisTakehiro Takahashi, Yoshihide Asano, Yohei Ichimura, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic SclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Pageof 4